Plano Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
34
- Latest Deal Type
-
Series A1
- Latest Deal Amount
-
$6.47M
- Investors
-
3
Plano General Information
Description
Developer of a science-based parental control application designed to keep children cyber-safe and their eyes healthy. The company's software offers eye health check software, events and games workshops, and myopia screen management software, enabling people to tackle the epidemic and get rid of myopia.
Contact Information
Website
www.plano.coCorporate Office
- 30 Cecil Street, Prudential Tower
- Number 19-08
- Singapore, 049712
- Singapore
Corporate Office
- 30 Cecil Street, Prudential Tower
- Number 19-08
- Singapore, 049712
- Singapore
Plano Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC (Series A1) | 30-Nov-2023 | $6.47M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 11-Nov-2019 | Completed | Startup |
Plano Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A1 | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Plano Patents
Plano Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023195919-A2 | Method for predicting risk of developing myopia | Inactive | 05-Apr-2022 | ||
| WO-2023195919-A3 | Method for predicting risk of developing myopia | Inactive | 05-Apr-2022 | ||
| AU-2017293323-A1 | Apparatus and method for monitoring use of a device | Active | 04-Jul-2016 | ||
| AU-2017293323-B2 | Apparatus and method for monitoring use of a device | Active | 04-Jul-2016 | ||
| GB-2567971-B | Apparatus and method for monitoring use of a device | Inactive | 04-Jul-2016 | G16H40/63 |
Plano Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Plano Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Santen Pharmaceutical Asia | Corporation | Minority | ||
| SEEDS Capital | Corporate Venture Capital | Minority | ||
| Meriton Capital | Corporation | Minority |
Plano FAQs
-
When was Plano founded?
Plano was founded in 2017.
-
Where is Plano headquartered?
Plano is headquartered in Singapore, Singapore.
-
What is the size of Plano?
Plano has 34 total employees.
-
What industry is Plano in?
Plano’s primary industry is Other Healthcare Technology Systems.
-
Is Plano a private or public company?
Plano is a Private company.
-
What is the current valuation of Plano?
The current valuation of Plano is .
-
What is Plano’s current revenue?
The current revenue for Plano is .
-
How much funding has Plano raised over time?
Plano has raised $8.31M.
-
Who are Plano’s investors?
Santen Pharmaceutical Asia, SEEDS Capital, and Meriton Capital have invested in Plano.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
